Navigation Links
Onyx Pharmaceuticals Reports Third Quarter 2011 Financial Results
Date:11/2/2011

60;210,142$195,372License revenue

-59,165-59,165Total revenue

75,041122,861210,142254,537Operating expenses:Research and development (1) (2)58,53244,568184,071131,394Selling, general and administrative (1)42,64225,924115,34977,293Contingent consideration

5,9455,62223,195101,107Lease termination exit costs

130-10,857-Total operating expenses

107,24976,114333,472309,794Income (loss) from operations

(32,208)46,747(123,330)(55,257)Investment income

4356281,7282,198Interest expense

(5,112)(4,943)(15,155)(14,467)Other income (expense) (3)

25(862)(3,776)(862)Income (loss) before provision (benefit) for income taxes

(36,860)41,570(140,533)(68,388)Provision (benefit) for income taxes

-7032(662)Net (loss) income

$(36,860)$41,500$ (140,565)$ (67,726)Net (loss) income per share:Basic

$
(0.58)$
.66$
(2.22)$
(1.08)Diluted (4)$
(0.58)$
.66$
(2.22)$
(1.08)Computation of diluted shares:Basic

63,55562,70763,32862,562Dilutive effect of options

-142--Diluted (4)63,55562,84963,32862,562(1)Includes employee stock-based compensation charges of:Research and development

$
,988$   1,075$
4,808$
3,090Selling, general, and administrative

6,6854,79917,56513,502Total employee stock-based compensation

$
8,673$   5,874$
22,373$   16,592(2) Includes a $12.7 million non-cash expense related to the unamortized balance of funding provided to S*BIO which was recorded in the first quarter of 2011.

(3) Includes a $3.0 million impairment charge which reflects the reassessment of the fair value of Onyx's equity investment in S*BIO during the first quarter of 2011.

(4) Under the "if-converted" method, interest and issuance costs and potential common shares related to the Company's convertible senior notes were excluded in the computation of diluted per share amounts for the three and
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  TechAtlas Group has ... their competitive landscape map for the Chronic Kidney ... 90 international companies with drugs and devices currently ... and its sequelae. (Logo:  ... , hypertension - renal denervation , ...
(Date:5/17/2013)... 17, 2013  Boehringer Ingelheim will contribute to ... the American Thoracic Society International Conference (ATS 2013) ... 17 – 22. Data will highlight ... treatment of chronic obstructive pulmonary disease (COPD) [Spiriva® ... investigational compounds for asthma, idiopathic pulmonary fibrosis (IPF) ...
(Date:5/17/2013)... 2013 Sinovac Biotech Ltd. (Nasdaq: SVA ... , today announced that it will release its unaudited ... before market on Tuesday, May 28, 2013.  The Company will ... 8:00 a.m. EDT (May 28, 2013 at 8:00 p.m. China ... an update on recent corporate developments. To access ...
Breaking Medicine Technology:TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3
... 22, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: ... announced today it has filed its Annual Report on Form ... year ended December 31, 2010 on April 22, 2011.  The ... www.sec.gov . The Company will provide a hard ...
... One hundred and eighty miles — Houston to Austin, ... MS 150 overcame on April 16 and 17 in a ... sponsored by The SCOOTER Store , the nation,s leading ... ride and raised nearly $20,000 toward the cause. ...
Cached Medicine Technology:Sinovac Files Annual Report on Form 20-F 2The SCOOTER Store Supports Fight Against Multiple Sclerosis 2
(Date:5/19/2013)... spring arrived late this year in parts of the ... strong, according to a sinus expert at the University ... professor in the university,s division of otolaryngology, said a ... season. However, some simple strategies can help people manage ... "Tree pollen has been bad for several weeks ...
(Date:5/19/2013)... Louis, MO (PRWEB) May 19, 2013 ... Conference, May 19-22, 2013, at the Walt Disney World ... latest trends in supply chain innovation, care delivery and ... much different dynamic in all healthcare markets, ... part of the conversation,” said Todd Ebert, Amerinet president ...
(Date:5/19/2013)... May 19, 2013 Actos lawsuit ... litigation now underway in U.S. District Court, Western District ... dated May 3rd, the Court has modified the litigation’s ... eight cases rather than four. The next Status Conference ... May 23rd. (In re: Actos Product Liability Litigation, MDL ...
(Date:5/19/2013)... 19, 2013 According to a ... and Forecast (2013 – 2018): By Applications (Healthcare ... Technology (CCD, CMOS, Contact IS, Infrared, X-Ray) And ... sensor market was $8.00 billion in 2012 and ... at an estimated CAGR of 3.84% from 2013 ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Fat Burning ... loss program that provides people with fat burning ... people order this Fat Burning Furnace package, people will ... that they can download quickly. The Fat Burning Furnace ... helps people build lean muscle mass. In addition, this ...
Breaking Medicine News(10 mins):Health News:Managing Seasonal Allergies 2Health News:Healthcare Leaders Gather at 2013 Amerinet Member Conference to Share New Ways to Reduce Costs and Enhance Care Delivery 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool 2
... element in making U.S. medical care more effective and efficient, ... the Stanford University School of Medicine shows that electronic records ... in 2003 and 2004. ,Of 17 quality indicators ... in 14 measures. In two areas, better quality was associated ...
... backed by sturdy cardboard it shows in neat, printed script ... ,Next to it, propped up against one of the ancient ... the 28-year-old bachelor proudly donning his military uniform. ... dozens of other parents amble past and take a look ...
... claims they can soon release the worlds first blood test that ... of UK will stand to save billions of pounds per year, ... in the western world, costs the NHS up to 17 billion ... a series of proteins, which are most commonly found in those ...
... London are long overdue but it is unclear how the ... patient care in the capital , BMA leaders claim. ... said: There is a case for changing how some services ... these proposals may not be in the best interests of ...
... to help dialysis patients ,One of the ... to live a better quality life, dialysis-dependent patients, needs ... is a very significant part of the dialysis process. ... production of red blood cells in bone marrow is ...
... The U.S. obesity prevalence increased from 13 percent to ... researchers at the Johns Hopkins Bloomberg School of Public ... obesity and overweight has increased at an average rate ... the past three decades. , Some minority ...
Cached Medicine News:Health News:Electronic Health Records Shows No Improvement in Quality of Outpatient Care 2Health News:Electronic Health Records Shows No Improvement in Quality of Outpatient Care 3Health News:Parental Match-making Blossoms in a Beijing Park 2Health News:Parental Match-making Blossoms in a Beijing Park 3Health News:Simple Blood Test May Predict Alzheimers Disease 2Health News:Polyclinics Could Threaten NHS Services, Warns BMA 2Health News:Analysis of Hemoglobin Level Control in Dialysis Patients 2Health News:Analysis of Hemoglobin Level Control in Dialysis Patients 3Health News:U.S Shows Increased Obesity Rate 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: